Ribosome biogenesis and control of cell proliferation: p53 is not alone

Cancer Research

Volumn 72, Issue 7, 2012, Pages 1602-1607

  Donati, Giulio ^a,b   Montanaro, Lorenzo ^a   Derenzini, Massimo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; CYTOTOXIC AGENT; DNA DIRECTED RNA POLYMERASE; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN; RIBOSOME RNA; TRANSCRIPTION FACTOR E2F1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOGENESIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; DRUG TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; RIBOSOME BIOGENESIS; RNA SYNTHESIS; RNA TRANSCRIPTION;

ANIMALS; BIOGENESIS; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; HUMANS; NEOPLASMS; RIBOSOMES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859393349     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3992     Document Type: Review

References (41)

1. Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nat Cell Biol 2000;2:E71-2.
2. Sollner-Webb B, Tower J. Transcription of cloned eukaryotic ribosomal RNA genes. Ann Rev Biochem 1986;55:801-83.
3. Lempiainen H, Shore D. Growth control and ribosomebiogenesis. Curr Opin Cell Biol 2009;21:855-63.
4. Grummt I. Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev 2003;17: 1691-702. (Pubitemid 36870332)
5. Riddle VG, Pardee AB, Rossow PW. Growth control of normal and transformed cells. J Supramol Struct 1979;11:529-38. (Pubitemid 10067164)
6. Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 2000; 288:2045-7. (Pubitemid 30397685)
7. Derenzini M, Montanaro L, Chilla A, Tosti E, Vici M, Barbieri S, et al. Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells. J Cell Physiol 2005;202:483-91. (Pubitemid 40041319)
8. Mayer C, Grummt I. Cellular stress and nucleolar function. Cell Cycle 2005;4:1036-8. (Pubitemid 41365359)
9. Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009;16:369-77.
10. Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010;29: 4253-60.
11. Grimm T, Holzel M, Rohrmoser M, Harasim T, Malamoussi A, Gruber-Eber A, et al. Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex. Nucleic Acids Res 2006;34:3030-43. (Pubitemid 44540430)
12. Dai MS, Arnold H, Sun XX, Sears R, Lu H. Inhibition of c-Myc activity by ribosomal protein L11. EMBO J 2007;26:3332-45. (Pubitemid 47123541)
13. Li J, Yu L, Zhang H, Wu J, Yuan J, Li X, et al. Down-regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells. Cancer Sci 2009;100:2255-60.
14. Iadevaia V, Caldarola S, Biondini L, Gismondi A, Karlsson S, Dianzani I, et al. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression. Oncogene 2010;29:5490-9.
15. Donati G, Brighenti E, Vici M, Mazzini G, Trere D, Montanaro L, et al. Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J Cell Sci 2011;124:3017-28.
16. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-12. (Pubitemid 41039110)
17. Iwakuma T, Lozano G. MDM2, an introduction. Mol Cancer Res 2003;1:993-1000. (Pubitemid 38044974)
18. Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004;279: 44475-82. (Pubitemid 39430853)
19. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003;23:8902-12. (Pubitemid 37433388)
20. Lohrum MAE, Ludwig RL, Kubbutat MHG, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003;3:577-87. (Pubitemid 36808652)
21. Bhat KP, Itahana K, Jin A, Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition induced p53 activation. EMBO J 2004;23:2402-12. (Pubitemid 38954847)
22. Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004;24:7654-68. (Pubitemid 39121491)
23. Jin A, Itahana K, O'Keefe K, Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004;24: 7669-80. (Pubitemid 39121492)
24. Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007;26:5029-37. (Pubitemid 47206956)
25. Yuan X, Zhou Y, Casanova E, Chai M, Kiss E, Grone HJ, et al. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell 2005;19:77-87. (Pubitemid 40884659)
26. Brodsky MH, Weinert BT, Tsang G, Rong YS, McGinnis NM, Golic KG, et al. Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Mol Cell Biol 2004;24:1219-31. (Pubitemid 38112184)
27. Simpson P, Morata G. Differential mitotic rates and patterns of growth in compartments in the Drosophila wing. Dev Biol 1981;85: 299-308. (Pubitemid 13142508)
28. Grewal SS, Evans JR, Edgar BA. Drosophila TIF-IA is required for ribosome synthesis and cell growth and is regulated by the TOR pathway. J Cell Biol 2007;179:1105-13. (Pubitemid 350277730)
29. Bernstein KA, Bleichert F, Bean JM, Cross FR, Baserga SJ. Ribosome biogenesis is sensed at the Start cell cycle checkpoint. Mol Biol Cell 2007;18:953-64. (Pubitemid 46402877)
30. Montanaro L, Mazzini G, Barbieri S, Vici M, Nardi-Pantoli A, Govoni M, et al. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines. Cell Prolif 2007;40:532-49. (Pubitemid 47063287)
31. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res 2008;68:5076-85.
32. Zhang Z, Wang H, Li M, Rayburn ER, Agrawal S, Zhang R. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway. Oncogene 2005;24:7238-47. (Pubitemid 41679285)
33. Stevens C, La Thangue NB. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 2004;3:1071-9. (Pubitemid 38997950)
34. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010;10:301-9.
35. Soussi T, Dehouche K, Béroud C. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 2000;15:105-13. (Pubitemid 30036177)
36. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996;88:1442-55. (Pubitemid 26340046)
37. Drygin D, Lin A, Bliesath J,HoCB, O'Brien SE, Proffitt C, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res 2010;71:1418-30.
38. Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstrom MS, et al. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010;18:231-43.
39. Montanaro L, Treré D, Derenzini M. Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta 2012;1825:101-10.
40. Molina-Privado I, Rodriguez-Martinez M, Rebollo P, Martin-Perez D, Artiga MJ, Menarguez J, et al. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma. Cancer Res 2009;69:4052-8.
41. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, et al. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 2010;120:4478-92.